Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
200 participants
INTERVENTIONAL
2023-03-01
2024-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Telephone Support Intervention to Improve Breastfeeding
NCT00717496
Recombinant Human Prolactin for Lactation Induction
NCT00181623
Breastfeeding Education Support Tool for Baby
NCT03533725
Implementation Strategy for a Breastfeeding Guideline in Primary Care
NCT01474096
Project to Promotion of Breastfeeding
NCT03357549
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
From January 1 2024 through to March 31st 2024 midwives will present to patients attending their 24 week antenatal appointment a breastfeeding toolkit card.
The trial compares breastfeeding rates across patients who receive the card and those whose 24-week antenatal appointment occurred in the three months October 1 2023 - December 31 2023.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SEQUENTIAL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Breastfeeding toolkit card
50% of participants will be allocated to the intervention group, and receive a breastfeeding toolkit card at the 24 week appointment.
The Breastfeeding toolkit provides advice on circumventing common breastfeeding problems and contact details for breastfeeding support services.
Breastfeeding toolkit card
The card is delivered at 24 weeks and is also referred to in the 32 and 36 week antenatal meetings. It will also be referred to in the first 24 hours post-partum and in home visits.
No planning card
50% of women will receive routine antenatal care only.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Breastfeeding toolkit card
The card is delivered at 24 weeks and is also referred to in the 32 and 36 week antenatal meetings. It will also be referred to in the first 24 hours post-partum and in home visits.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
17 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NHS Grampian
OTHER_GOV
University of Stirling
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
David Comerford
Professor of Behavioural Science
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Comerford
Role: PRINCIPAL_INVESTIGATOR
Stirling University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Stirling
Stirling, Stirlingshire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRAS: 316125
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.